Diverse Osteoclastogenesis of Bone Marrow from Mandible Versus Long Bone

Overview

Journal J Periodontol

Date 2013 Sep 6

PMID 24003963

Citations 17

Authors

Thawinee Chaichanasakul

Benjamin Kang

Olga Bezouglaia

Tara L Aghaloo

Sotirios Tetradis

Affiliations

Soon will be listed here.

Abstract

Background: Mandibles (MB) and maxillae possess unique metabolic and functional properties and demonstrate discrete responses to homeostatic, mechanical, hormonal, and developmental stimuli. Osteogenic potential of bone marrow stromal cells (BMSCs) differs between MB versus long bones (LB). Furthermore, MB- versus LB-derived osteoclasts (OCs) have disparate functional properties. This study explores the osteoclastogenic potential of rat MB versus LB marrow in vitro and in vivo under basal and stimulated conditions.

Methods: Bone marrow from rat MB and LB was cultured in osteoblastic or osteoclastic differentiation media. Tartrate-resistant acid phosphatase (TRAP) staining, resorption pit assays, and real-time polymerase chain reaction were performed. Additionally, osmotic mini-pumps were implanted in animals, mandibles and tibiae were isolated, and multinucleated cells (MNCs) were measured.

Results: MB versus LB marrow cultures that were differentiated with receptor activator of nuclear factor-κB ligand (RANKL) and macrophage colony-stimulating factor produced more TRAP(+) MNCs and greater resorptive area. To explore MB versus LB BMSC-supported osteoclastogenesis, confluent BMSCs were cultured with parathyroid hormone (PTH), 1,25-dihydroxyvitamin D3 (1,25D3), or PTH+1,25D3. 1,25D3- or PTH+1,25D3-treated LB BMSCs expressed significantly higher RANKL and lower osteoprotegerin (OPG) mRNA and increased RANKL:OPG ratio. When whole marrow was cultured with PTH+1,25D3, more TRAP(+) MNCs were seen in LB versus MB cultures. Ultimately, rats were infused with PTH+1,25D3, and MB versus tibia MNCs were measured. Hormonal stimulation increased osteoclastogenesis in both MB and tibiae. However, higher TRAP(+) MNC numbers were observed in tibiae versus MB under basal and hormonal stimulation.

Conclusion: Collectively, these data illustrate differences of both osteoclastogenic potential and OC numbers of MB versus LB marrow.

Citing Articles

Influence of bone morphogenetic protein (BMP) signaling and masticatory load on morphological alterations of the mouse mandible during postnatal development.

Uptegrove A, Chen C, Sahagun-Bisson M, Kulkarni A, Louie K, Ueharu H Arch Oral Biol. 2024; 169:106096.

PMID: 39341045 PMC: 11609011. DOI: 10.1016/j.archoralbio.2024.106096.

Beyond bone volume: Understanding tissue-level quality in healing of maxillary vs. femoral defects.

Romanowicz G, Zhang L, Bolger M, Lynch M, Kohn D Acta Biomater. 2024; 187:409-421.

PMID: 39214162 PMC: 11890190. DOI: 10.1016/j.actbio.2024.08.042.

Diabetes mellitus exacerbates inflammation in a murine model of ligature-induced peri-implantitis: A histological and microtomographic study.

Silva D, Monajemzadeh S, Casarin M, Chalmers J, Lubben J, Magyar C J Clin Periodontol. 2024; 51(11):1511-1523.

PMID: 39135333 PMC: 11487626. DOI: 10.1111/jcpe.14051.

Mouse mandibular-derived osteoclast progenitors have differences in intrinsic properties compared with femoral-derived progenitors.

Clark R, Park S, Bradley E, Mansky K, Tasca A JBMR Plus. 2024; 8(5):ziae029.

PMID: 38606149 PMC: 11008737. DOI: 10.1093/jbmrpl/ziae029.

Pathophysiology of Medication-Related Osteonecrosis of the Jaw-A Minireview.

Tetradis S, Allen M, Ruggiero S JBMR Plus. 2023; 7(8):e10785.

PMID: 37614299 PMC: 10443081. DOI: 10.1002/jbm4.10785.

References

Martinez-Maestre M, Gonzalez-Cejudo C, Machuca G, Torrejon R, Castelo-Branco C . Periodontitis and osteoporosis: a systematic review. Climacteric. 2010; 13(6):523-9. DOI: 10.3109/13697137.2010.500749. View

Gokhale S, Padhye A . Future prospects of systemic host modulatory agents in periodontal therapy. Br Dent J. 2013; 214(9):467-71. DOI: 10.1038/sj.bdj.2013.432. View

Price U, Le H, Powell S, Schmid M, D. B. Marx , Zhang Y . Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss. J Periodontal Res. 2013; 48(5):541-8. DOI: 10.1111/jre.12036. View

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S . Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998; 95(7):3597-602. PMC: 19881. DOI: 10.1073/pnas.95.7.3597. View

Li H, Jiang X, Delaney J, Franceschetti T, Bilic-Curcic I, Kalinovsky J . Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol. 2010; 176(5):2405-13. PMC: 2861105. DOI: 10.2353/ajpath.2010.090704. View

Ruggiero S, Dodson T, Assael L, Landesberg R, Marx R, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. J Oral Maxillofac Surg. 2009; 67(5 Suppl):2-12. DOI: 10.1016/j.joms.2009.01.009. View

Martin T, Ng K . Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem. 1994; 56(3):357-66. DOI: 10.1002/jcb.240560312. View

Sodek J, McKee M . Molecular and cellular biology of alveolar bone. Periodontol 2000. 2001; 24:99-126. DOI: 10.1034/j.1600-0757.2000.2240106.x. View

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

10.

Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N . Modulation of osteoclast differentiation by local factors. Bone. 1995; 17(2 Suppl):87S-91S. DOI: 10.1016/8756-3282(95)00185-g. View

11.

Megson E, Kapellas K, Bartold P . Relationship between periodontal disease and osteoporosis. Int J Evid Based Healthc. 2011; 8(3):129-39. DOI: 10.1111/j.1744-1609.2010.00171.x. View

12.

Everts V, de Vries T, Helfrich M . Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta. 2009; 1792(8):757-65. DOI: 10.1016/j.bbadis.2009.05.004. View

13.

Yamaza T, Ren G, Akiyama K, Chen C, Shi Y, Shi S . Mouse mandible contains distinctive mesenchymal stem cells. J Dent Res. 2010; 90(3):317-24. PMC: 3034836. DOI: 10.1177/0022034510387796. View

14.

Xiong J, Onal M, Jilka R, Weinstein R, Manolagas S, OBrien C . Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17(10):1235-41. PMC: 3192296. DOI: 10.1038/nm.2448. View

15.

Marx R . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003; 61(9):1115-7. DOI: 10.1016/s0278-2391(03)00720-1. View

16.

Everts V, Korper W, Jansen D, Steinfort J, Lammerse I, Heera S . Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 1999; 13(10):1219-30. DOI: 10.1096/fasebj.13.10.1219. View

17.

Jobin J, Bonjour J . Compensatory renal growth: modulation by calcium PTH and 1,25-(OH)2D3. Kidney Int. 1986; 29(6):1124-30. DOI: 10.1038/ki.1986.117. View

18.

Pradeep A, Sharma A, Rao N, Bajaj P, B Naik S, Kumari M . Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial. J Periodontol. 2012; 83(10):1322-8. DOI: 10.1902/jop.2012.110292. View

19.

Liu H, Guo J, Wang L, Chen N, Karaplis A, Goltzman D . Distinctive anabolic roles of 1,25-dihydroxyvitamin D(3) and parathyroid hormone in teeth and mandible versus long bones. J Endocrinol. 2009; 203(2):203-13. DOI: 10.1677/JOE-09-0247. View

20.

Guiglia R, Di Fede O, Russo L, Sprini D, Rini G, Campisi G . Osteoporosis, jawbones and periodontal disease. Med Oral Patol Oral Cir Bucal. 2012; 18(1):e93-9. PMC: 3548653. DOI: 10.4317/medoral.18298. View